Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility?
Author: Keir, A.
Dunn, M.
Callum, J.
Citation: Journal of Paediatrics and Child Health, 2013; 49(12):1072-1078
Publisher: Blackwell Publishing Asia
Issue Date: 2013
ISSN: 1034-4810
Statement of
Amy K Keir, Michael Dunn and Jeannie Callum
Abstract: The use of intravenous immunoglobulin in isoimmune haemolytic disease due to ABO incompatibility is recommended by the American Academy of Pediatrics and the National Blood Authority, Australia. However, the evidence these recommendations are based on appears limited and, in some instances, outdated. In our article, we review the current available literature to help answer the question, ‘In infants with isoimmune haemolytic disease due to ABO incompatibility [P], does use of intravenous immunoglobulin and intensive phototherapy [I] compared with intensive phototherapy alone [C] provide any clinically important benefits [O]?
Keywords: anaemia
Rights: © 2013 The Authors
DOI: 10.1111/jpc.12440
Appears in Collections:Aurora harvest 4
Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.